Anti-tubulin agents constitute a large class of compounds with broad activity both in solid
tumors and hematologic malignancies, due to the interference with microtubule dynamics …

The role of hematopoietic cell transplantation (HCT) in the therapy of Hodgkin lymphoma
(HL) in pediatric and adult patients is reviewed and critically evaluated in this systematic …

Children, adolescents, and young adults (CAYA) with relapsed/refractory (R/R) classic
Hodgkin lymphoma (cHL) without complete metabolic response (CMR) before autologous …

Background Patients with primary refractory Hodgkin's lymphoma or early relapse have a
poor prognosis. Although many salvage regimens have been developed, there is no …

Purpose Anticipating toxicities with gemcitabine is an ongoing story, and deregulation in
cytidine deaminase (CDA) could be associated with increased risk of developing early …

Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens
are focused on improving treatment efficacy while decreasing the risk of late effects of …

Hodgkin lymphoma, a hematological malignancy of lymphoid origin that typically arises from
germinal-center B cells, has an excellent overall prognosis. However, the treatment of …

PURPOSE Population-based studies of children and adolescents with Hodgkin lymphoma
(HL) report a survival disadvantage in nonwhite—non-Hispanic black (NHB) and Hispanic …

Hodgkin lymphoma (HL) is a lymphoid malignancy that is typically derived from germinal-
center B cells. EBV infection, mutations in NF-κB pathway genes, and genetic susceptibility …

We conducted a multi-center phase II trial of gemcitabine (G), carboplatin (C),
dexamethasone (D), and rituximab (R) in order to examine its safety and efficacy as an …